Clinical Trial: Investigating a Personalized Approach to Anti-Platelet Therapy

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602257) titled 'Investigating a Personalized Approach to Anti-Platelet Therapy' on May 15.

Brief Summary: RAPID PREVENT aims to identify if a personalized (targeted) anti-platelet strategy will reduce bleeding events when compared to the current standard anti-platelet therapy.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: High Risk Bleeding

Intervention: DRUG: Genotyping guided therapy for anti-platelet management

Participants that are carriers of the CYP2C19 gene will receive either Ticagrelor monotherapy, or dual therapy with Ticagrelor and Aspirin.

Participants that are not carriers of the CYP2C19 gene will receive eithe...